Advanced Biomed Inc (ADVB)
Advanced Biomed Inc. is a common stock listing of a healthcare company focused on microfluidic biochip research and development for precision oncology applications in Taiwan. The company’s work centers on tools used in cancer detection, diagnosis, and treatment support, including automated sample preparation, rare-cell detection, circulating tumor cell capture, and related analysis systems. Its product set includes devices such as A+Pre, AC-1000, A+SCDrop, and A+CellScan, along with associated biochips and immunochromogenic kits designed to identify different tumor-related cell types and markers. Advanced Biomed is also developing A+LCGuard for early lung cancer screening and operates medical clinics in China. Founded in 2014, the company is headquartered in New York, New York.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-ADVB
|
$7.33
|
-6.1% Downside
|
Fair
|
—
|
—
|
—
|
Good
|
—
|
—
|
—
|
0.0%
|
October 8, 2026
|
3.1x
|
1.6x
|
—
|
14.704 M
|
12.804 M
|
4.6%
|
45.6%
|
4.4
|
—
|
-61.9%
|
